Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cephalexin measurement |
Component |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental cephalexin poisoning |
Causative agent (attribute) |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional cephalexin poisoning |
Causative agent (attribute) |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cephalexin poisoning of undetermined intent |
Causative agent (attribute) |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cephalexin adverse reaction |
Causative agent (attribute) |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to cephalexin |
Causative agent (attribute) |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cephalexin overdose |
Causative agent (attribute) |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental cephalexin overdose |
Causative agent (attribute) |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional cephalexin overdose (disorder) |
Causative agent (attribute) |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cephalexin overdose of undetermined intent |
Causative agent (attribute) |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin monohydrate 250 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cefalexin 500mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cephalexin 125mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cephalexin 250mg/5mL syrup (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cephalexin monohydrate 500mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cephalexin monohydrate 250mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cephalexin monohydrate 125mg/5 mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cephalexin monohydrate 250mg/5 mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning by cephalexin |
Causative agent (attribute) |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cefalexin hydrochloride |
Is a |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cephalexin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin monohydrate 250 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cefalexin monohydrate 500 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cefalexin monohydrate |
Is a |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cefalexin 25 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cefalexin 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental cephalexin poisoning |
Causative agent (attribute) |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional cephalexin poisoning |
Causative agent (attribute) |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin monohydrate 333 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cefalexin monohydrate 750 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to cephalexin |
Causative agent (attribute) |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing cefalexin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cefalexin hydrochloride |
Is modification of (attribute) |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cefalexin monohydrate |
Is modification of (attribute) |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cefalexin 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cefalexin 25 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cefalexin 25 mg/mL oral suspension |
Has precise active ingredient |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cefalexin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only cefalexin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cefalexin 500 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cefalexin 500 mg oral tablet |
Has precise active ingredient |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin (as cefalexin monohydrate) 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin (as cefalexin monohydrate) 500 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin (as cefalexin monohydrate) 250 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cefalexin anhydrous (substance) |
Is modification of (attribute) |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cefalexin anhydrous (as cefalexin) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin anhydrous (as cefalexin) 25 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
False |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin anhydrous (as cefalexin) 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cefalexin anhydrous (as cefalexin) 50 mg/mL oral solution |
Has precise active ingredient |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cefalexin 500 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cefalexin 500 mg oral capsule |
Has precise active ingredient |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin 250 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin 250 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin 750 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin 750 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin 333 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin 333 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cefalexin 25 mg/mL oral solution |
Has precise active ingredient |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cefalexin 25 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin 125 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin 125 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin 500 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin 500 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
Has precise active ingredient |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cefalexin 250 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
Has basis of strength substance (attribute) |
True |
Cephalexin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |